Coverage
-
August 02, 2023
A District of Columbia federal judge has entered judgment in favor of the U.S. Food and Drug Administration in Vanda Pharmaceuticals' suit challenging the agency's refusal to streamline review of a drug meant to treat nausea in patients with a chronic gastric condition, according to an order issued Wednesday.
2 other articles on this case.
View all »